Earnings
Aurinia's R&D Spending Doubles To $16.6 Million As Tax Bill Flattens Profit
Pre-tax income rose to $38.7 million, but net income held at $31.7 million as taxes returned and buybacks stopped.
Aurinia Pharmaceuticals (AUPH) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
Pre-tax income rose to $38.7 million, but net income held at $31.7 million as taxes returned and buybacks stopped.
Earnings
Third-quarter LUPKYNIS sales rose 12%, and nine-month cash from operations reached $131.5 million.